Discontinuation of Antiseizure Medications in Patients With Brain Tumors
Katherine B. Peters(Haukeland University Hospital), Maciej Mrgula(Haukeland University Hospital), Karan Dixit(Northwestern University), Thomas Wychowski(Haukeland University Hospital), Jessica W. Templer(Haukeland University Hospital), Sonia Partap(Boston Medical Center), Tobias Walbert(Henry Ford Health System), Nicole J. Ullrich(Boston Children's Hospital), Elizabeth R. Gerstner(University of California, Los Angeles), Ashley Ghiaseddin(University of Florida), Maya Hrachova(Haukeland University Hospital), Anette Storstein(Haukeland University Hospital), Kaitlyn Melnick(University of Florida)
Cited by 15
Related Papers
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
|Neuro-Oncology|2015|665
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540